June 28, 2011 (San Diego) -- In people with diabetes, gastric banding is associated with fewer complications and lower costs over the long run than gastric bypass, the most commonly performed surgery for obesity in the U.S., researchers say.
Both procedures reduce the amount of care needed and associated health care costs for people with type 2 diabetes in the months immediately following surgery.
But by four years later, heath care use and costs increased for patients who underwent bypass surgery, while continuing to decline among those who got banding, says researcher Jason Lebowitz, a PharmD candidate at the University of Southern California in Los Angeles.
Allergan Inc., which makes the Lap-Band laparoscopic gastric banding device, funded the research. It was presented here at the annual meeting of the American Diabetes Association.